Goldman, Citi Among 22 Banks On CD&R’s Buyout Of Sanofi Unit
(Bloomberg) --Goldman Sachs Group Inc and Citigroup Inc. are among 22 banks set to provide Clayton Dubilier & Rice with buyout financing for a stake in Sanofi SA's consumer health division.
Lenders are expected to sign on to the deal to provide €8.65 billion ($9.4 billion) of euro- and dollar-denominated loan and bond financing in the coming days, according to people familiar with the deal, who asked not to be identified discussing private matters.
Seven lenders, including Barclays Plc, BNP Paribas SA, Citigroup Inc., Goldman Sachs Group Inc, Morgan Stanley and Societe Generale SA, are expected to act as global co-ordinators, the people said. The share of the global coordinators' fees is expected to be in the high single digits, and the shares of the 15 or so other banks will be in the low single digits, one of the people said.
Banks are eager to return to funding leveraged buyouts after the first Federal Reserve interest rate cut in four years raised hopes that debt costs are finally starting to ease. Such deals are some of the most lucrative operations in finance and the Sanofi buyout is one of the biggest in Europe so far this year.
Citi was advising CD&R on the sale, while Goldman Sachs and Morgan Stanley were sellside advisors. JPMorgan Chase & Co. advised France's PAI Partners on a rival bid. It's unclear whether the Wall Street giant will be among lenders financing the CD&R deal.
Representatives from Citi, Goldman Sachs, Societe Generale, BNP Paribas, JPMorgan, Morgan Stanley and CD&R declined to comment. Sanofi referred all questions to CD&R. A spokesperson for Barclays didn't immediately respond to a request for comment.
Fee squeeze
Each bank is receiving a lower share of the fee than would usually be expected in a deal of this size because the deal is being split 22 ways, an unusually large number. Sponsors are coming coming under pressure to gift roles to as many banks as possible due to the lack of recent large M&A deals.
Global coordinators tend to take a leading role in the sell down of debt to institutional investors, entitling them to more fees. Up to four of the seven banks could take charge of the euro term loan, while other global coordinators could take a solo spot leading the sell down of the rest, the people said.
Banks have signed funding commitments for a €5.45 billion term loan B split between euros and dollars, with target pricing of 350 basis points over Euribor for the euro component, and 325 basis points over SOFR for the US dollar tranche, Bloomberg previously reported.
There is also a €2 billion bridge to high-yield bond financing, with caps of 7.5% for the euro bonds and 8.5% for the dollars. Banks will also give around €1.2 billion of revolving credit facility.
CD&R will not be using the more than €1 billion of so-called back leverage that banks had lined up to help fund the equity check, as reported by Bloomberg. That's because it has secured a more than €1 billion payment-in-kind loan from private credit funds, the people said.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.